LUCENTIS RANIBIZUMAB INJECTION Trademark

Trademark Overview

On Thursday, June 22, 2006, a trademark application was filed for LUCENTIS RANIBIZUMAB INJECTION with the United States Patent and Trademark Office. The USPTO has given the LUCENTIS RANIBIZUMAB INJECTION trademark a serial number of 78914719. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, January 4, 2018. This trademark is owned by Genentech, Inc.. The LUCENTIS RANIBIZUMAB INJECTION trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF ANGIOGENESIS DISEASES AND DISORDERS, AND OCULAR DISEASES AND DISORDERS
lucentis ranibizumab injection

General Information

Serial Number78914719
Word MarkLUCENTIS RANIBIZUMAB INJECTION
Filing DateThursday, June 22, 2006
Status800 - REGISTERED AND RENEWED
Status DateThursday, January 4, 2018
Registration Number3386828
Registration DateTuesday, February 19, 2008
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 6, 2007

Trademark Statements

Description of MarkThe mark consists of the words LUCENTIS RANIBIZUMAB INJECTION and an oval inside a crescent above the word LUCENTIS.
Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF ANGIOGENESIS DISEASES AND DISORDERS, AND OCULAR DISEASES AND DISORDERS
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"RANIBIZUMAB INJECTION"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 28, 2006
Primary Code005
First Use Anywhere DateFriday, June 30, 2006
First Use In Commerce DateFriday, June 30, 2006

Trademark Owner History

Party NameGenentech, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990
Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940804990
Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 940804990

Trademark Events

Event DateEvent Description
Friday, September 22, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 27, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 28, 2006NEW APPLICATION ENTERED
Thursday, June 29, 2006NOTICE OF DESIGN SEARCH CODE MAILED
Monday, October 23, 2006ASSIGNED TO EXAMINER
Thursday, October 26, 2006TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, October 26, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 23, 2007TEAS STATEMENT OF USE RECEIVED
Monday, November 13, 2006EXAMINERS AMENDMENT -WRITTEN
Monday, November 13, 2006EXAMINERS AMENDMENT E-MAILED
Monday, November 13, 2006EXAMINER'S AMENDMENT ENTERED
Monday, November 20, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 7, 2006ASSIGNED TO LIE
Friday, December 8, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 17, 2007NOTICE OF PUBLICATION
Tuesday, February 6, 2007PUBLISHED FOR OPPOSITION
Tuesday, May 1, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Saturday, December 1, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 23, 2007SOU TEAS EXTENSION RECEIVED
Tuesday, October 23, 2007SOU EXTENSION 1 FILED
Tuesday, October 23, 2007USE AMENDMENT FILED
Tuesday, November 6, 2007SOU EXTENSION 1 GRANTED
Tuesday, November 6, 2007STATEMENT OF USE PROCESSING COMPLETE
Saturday, December 1, 2007SU-EXAMINER'S AMENDMENT WRITTEN
Saturday, December 1, 2007EXAMINERS AMENDMENT E-MAILED
Saturday, December 1, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, December 1, 2007EXAMINER'S AMENDMENT ENTERED
Thursday, January 4, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 15, 2008ASSIGNED TO LIE
Wednesday, January 16, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, February 19, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, November 12, 2013TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 12, 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Saturday, November 23, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, November 23, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, November 24, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
Tuesday, December 5, 2017TEAS SECTION 8 & 9 RECEIVED
Monday, April 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 11, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, August 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 4, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, January 4, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, January 4, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, May 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Related Keywords

injection ranibizumab lucentis diseases disorders ocular angiogenesis preparations treatment pharmaceutical